Investigational therapies for the pharmacological treatment of alcoholism.

about

Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision.Pharmacotherapy of alcoholism - an update on approved and off-label medications.

P2860

Q36231851-84181670-C3F9-44FC-AD5C-6BE86565DA2D Q43061723-7B018F2C-3821-42C7-B07F-E85F30DEB87D

P2860

Investigational therapies for the pharmacological treatment of alcoholism.

Item

http://www.wikidata.org/entity/Q38244035

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Investigational therapies for the pharmacological treatment of alcoholism.

@en

type

Item

label

Investigational therapies for the pharmacological treatment of alcoholism.

@en

prefLabel

Investigational therapies for the pharmacological treatment of alcoholism.

@en

P1476

Investigational therapies for the pharmacological treatment of alcoholism.

@en

P2093

Annemarie Heberlein

http://www.w3.org/2001/XMLSchema#string

Lorenzo Leggio

http://www.w3.org/2001/XMLSchema#string

Thomas Hillemacher

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence

Glutamate transporter 1: target for the treatment of alcohol dependence

Role of nucleus accumbens glutamatergic plasticity in drug addiction

Expression of ethanol-induced behavioral sensitization is associated with alteration of chromatin remodeling in mice

A single injection of the kappa opioid antagonist norbinaltorphimine increases ethanol consumption in rats

Neurokinin 1 receptor antagonism as a possible therapy for alcoholism

Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction

Evidence for the role of dopamine D3 receptors in oral operant alcohol self-administration and reinstatement of alcohol-seeking behavior in mice

Antagonists at metabotropic glutamate receptor subtype 5: structure activity relationships and therapeutic potential for addiction

Involvement of NMDA receptors in alcohol-mediated behavior: mice with reduced affinity of the NMDA R1 glycine binding site display an attenuated sensitivity to ethanol

P304

17-30

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.2014.954037

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25164385

http://www.w3.org/2001/XMLSchema#string

P921

alcoholism

Investigational therapies for the pharmacological treatment of alcoholism.

about

P2860

P2860

Investigational therapies for the pharmacological treatment of alcoholism.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921